Fundraising Fox

Applied Therapeutics

New York, US · Founded 2016 · Delaware corporation · 2 known investors

appliedtherapeutics.com ↗

Applied Therapeutics is a biopharmaceutical company developing treatments for rare diseases, with a portfolio focused on Classical Galactosemia and CMT-SORD. Its lead investigational drug, govorestat, targets disease pathways such as galactitol and sorbitol reduction.

BiotechHealthtech

Founders & leadership

Applied Therapeutics was founded in 2016 by Shoshana Shendelman.

SS
Shoshana ShendelmanFounder

Board

LF
Les FuntleyderBoard director

Investors · 2

Evolution VC PartnersNew York
AlexandriareportedPasadenavia Joel S. Marcus · board

Reported raises · per SEC filings

Form D private placements

$189.2M disclosed across 6 rounds · 2017–2024

▶$100MraisedMar 2024 · 31 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Riccardo PerfettiExecutive Officer
  • Adam HansardExecutive Officer
  • Stacy J. KanterDirector
  • Catherine ThorpeExecutive Officer
  • Les FuntleyderExecutive Officer, Director
  • Joel S. MarcusDirector
  • Shoshana ShendelmanExecutive Officer, Director
  • Teena LernerDirector
  • Jay SkylerDirector
Offering amount
$100M
Amount sold
$100M
Sales commissions
$7.5M
Placement agents
Robert W. Baird & Co. Inc., RBC Capital Markets, LLC, Leerink Partners LLC, UBS Securities LLC
First sale
Feb 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$30MraisedMay 2023 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Stacy J. KanterDirector
  • Joel S. MarcusDirector
  • Adam HansardExecutive Officer
  • Shoshana ShendelmanExecutive Officer, Director
  • Jay SkylerDirector
  • Les FuntleyderDirector
  • Riccardo PerfettiExecutive Officer
  • Teena LernerDirector
Offering amount
$30M
Amount sold
$30M
Sales commissions
$2.1M
Placement agents
UBS Securities LLC, SVB Securities LLC
First sale
Apr 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$20MraisedNov 2019 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Joel S. MarcusDirector
  • Stacy J. KanterDirector
  • Les FuntleyderDirector
  • Mark VignolaExecutive Officer
  • Riccardo PerfettiExecutive Officer
  • Shoshana ShendelmanExecutive Officer, Director
  • Teena LernerDirector
  • Jay SkylerDirector
Offering amount
$20M
Amount sold
$20M
Sales commissions
$1.3M
Placement agents
Collage Partners, a division of CIM Securities LLC
First sale
Nov 2019
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$27.2MraisedNov 2018 · 37 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Shoshana ShendelmanExecutive Officer, Director
  • Franklin BergerDirector
  • Les FuntleyderDirector
  • Teena LernerDirector
  • Joel MarcusDirector
Offering amount
$56.6M
Amount sold
$27.2M
Sales commissions
$521.7K
Placement agents
CIM Securities, LLC
First sale
Nov 2018
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6MraisedFeb 2018 · 23 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Les FuntleyderDirector
  • Joel MarcusDirector
  • Shoshana ShendelmanExecutive Officer, Director
  • Franklin BergerDirector
  • Teena LernerDirector
Offering amount
$6M
Amount sold
$6M
Sales commissions
$420K
Placement agents
a division of CIM Securities, LLC
First sale
Feb 2018
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.1MraisedFeb 2017 · 26 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Shoshana ShendelmanExecutive Officer, Director
  • Les FuntleyderDirector
Offering amount
$7M
Amount sold
$6.1M
Sales commissions
$560K
Placement agents
a division of CIM Securities, LLC
First sale
Jan 2017
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Bioworld183 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Companies competing with Applied Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Applied Therapeutics do?
Applied Therapeutics is a biopharmaceutical company developing treatments for rare diseases, with a portfolio focused on Classical Galactosemia and CMT-SORD. Its lead investigational drug, govorestat, targets disease pathways such as galactitol and sorbitol reduction.
Who founded Applied Therapeutics?
Applied Therapeutics was founded by Shoshana Shendelman in 2016.
Who are Applied Therapeutics's investors?
Applied Therapeutics's investors include Evolution VC Partners, Alexandria.
How much funding has Applied Therapeutics raised?
Applied Therapeutics has disclosed $189.2M raised across 6 rounds.
Where is Applied Therapeutics headquartered?
Applied Therapeutics is headquartered in New York, US.